BPOF 2026 | APGCS 2026

Biomarkers & Precision Oncology Forum

Moving the Needle in Precision Oncology
30th July 2026
Academia, Singapore

Biomarkers & Precision Oncology Forum

Core Pillars Shaping Personalized Cancer Care at BPOF

Advancing Precision Science

Expert-led sessions highlighting the latest research, diagnostics, and clinical innovations in biomarker-driven oncology across lung, breast, and gynaecological cancers.

Focused Dialogue

Cross-sector discussions among clinicians, researchers, and industry on real-world challenges and opportunities in applying biomarker strategies.

Real-World Clinical Perspectives

Practical insights and case-based experiences on integrating biomarker data into oncology practice.

Emerging Biomarker Insights

Updates on novel biomarkers, evolving molecular profiling trends, and their clinical and research implications

About BPOF

The Biomarkers and Precision Oncology Forum (BPOF) is a focused scientific meeting dedicated to advancing biomarker-driven precision cancer care. The 5th Edition of BPOF 2026 will take place on 30 July 2026 in Singapore.

The forum convenes international and regional experts in oncology, biomarker research, and precision medicine to share clinically relevant insights across lung, breast, and gynaecological cancers. Discussions will highlight biomarker discovery, validation, and real-world clinical application, with emphasis on evidence-based and translational approaches.

BPOF provides a platform for multidisciplinary exchange that supports innovation and improved patient outcomes in precision oncology.

BPOF Through the Years

1200

Total Registered Delegates

Participating Countries

Abstracts

Industry Partners

Welcome Message

Dear Colleagues and Friends,

We are pleased to introduce the upcoming Biomarkers and Precision Oncology Forum (BPOF 2026). BPOF brings together experts working in oncology, biomarker science, and precision medicine with a shared interest in advancing of biomarker-driven approaches in cancer care.

BPOF 2026 will be held on 30 July 2026 in Singapore and will provide a setting for the exchange of knowledge related to biomarker development, research progress, and evidence shaping personalized treatment strategies across key cancer types.

The forum aims to support scientific dialogue and collaboration by enabling participants to share perspectives, discuss emerging data, and consider how advances in biomarker science may inform clinical decision-making and patient care.

We look forward to welcoming you to Singapore for BPOF 2026.

Warm regards,
Organizing Committee – BPOF